Older couple completing the PAAG-8+ questionnaire at home

PAAG-8+
Questionnaire

Arthrosamid® (a registered trademark of Contura A/S.).

24-Month Clinical Benefit Stratification

Higher score

Greater likelihood of achieving MCID at 24 months

Lower score

Higher risk of limited benefit

Designed for

Shared decision-making, not absolute prediction

PAAG-8+ Questionnaire

Completed 0/8

Question 1 of 8

Age

How old are you?

Older age associated with higher odds of benefit in your cohort.

Please select an option before moving to the next question.

Clinical Disclaimer (PAAG-8+ Questionnaire)

The PAAG-8+ Questionnaire and associated scoring system are provided for information and shared decision-making purposes only. The tool has been developed from our own independent clinical study and real-world clinical experience within our specialist clinic, including an expanding cohort now exceeding 600 patients, and reflects outcomes achieved using our specific protocols and patient population.

The questionnaire does not constitute medical advice, does not provide diagnosis or treatment recommendations, and must not be used in isolation or generalised to other clinicians, centres, or settings. Scores represent an indicative estimate of potential clinical benefit, not a guarantee of outcome, and individual results may vary. Final clinical decisions should always be made following appropriate specialist consultation, clinical examination, imaging review, and informed discussion, in line with UK regulatory and medico-legal standards.

keep-team

Book an Arthrosamid® Assessment – London

Long-lasting relief starts with the right decision — not just an injection.

Book a consultation
Harley Street, London